Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Lorefice

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Plos One|August 1, 2012
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated allelesEleonora Cocco, Alessandra Meloni, Maria Rita Murru, et al.
European Journal of Neurology|December 26, 2024
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter studyViviana Nociti, Marina Romozzi, Luca Prosperini, et al.
Journal of the Neurological Sciences|January 14, 2025
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodiesViviana Nociti, Marina Romozzi, Pietro Annovazzi, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2023
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTsRocco Capuano, Luca Prosperini, Manuela Altieri, et al.
Neuroimage. Clinical|May 8, 2024
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.
Clinical and Experimental Medicine|December 2, 2022
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemicFederica Murgia, Maura Fiamma, Silvia Serra, et al.
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Mauro Zaffaroni, Lucia Moiola, et al.
Frontiers in Immunology|December 27, 2021
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis PatientsMaristella Pitzalis, Maria Laura Idda, Valeria Lodde, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Plos One|August 1, 2012
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated allelesEleonora Cocco, Alessandra Meloni, Maria Rita Murru, et al.
European Journal of Neurology|December 26, 2024
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter studyViviana Nociti, Marina Romozzi, Luca Prosperini, et al.
Journal of the Neurological Sciences|January 14, 2025
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodiesViviana Nociti, Marina Romozzi, Pietro Annovazzi, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2023
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTsRocco Capuano, Luca Prosperini, Manuela Altieri, et al.
Neuroimage. Clinical|May 8, 2024
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.
Clinical and Experimental Medicine|December 2, 2022
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemicFederica Murgia, Maura Fiamma, Silvia Serra, et al.
Multiple Sclerosis and Related Disorders|July 20, 2020
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems groupMarcello Moccia, Pietro Annovazzi, Maria Chiara Buscarinu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Mauro Zaffaroni, Lucia Moiola, et al.
Frontiers in Immunology|December 27, 2021
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis PatientsMaristella Pitzalis, Maria Laura Idda, Valeria Lodde, et al.
Pageof 10